Urine proteomics to detect biomarkers for chronic allograft dysfunction

Journal of the American Society of Nephrology

Volumn 20, Issue 2, 2009, Pages 428-435

  Quintana, Luí F ^a,e   Solé Gonzalez, Amanda ^a   Kalko, Susana G ^a   Bañon Maneus, Elisenda ^a   Solé, Manel ^b   Diekmann, Fritz ^a,d   Gutierrez Dalmau, Alex ^a   Abian, Joaquin ^c   Campistol, Josep M ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; POLYPEPTIDE; PROTEOME;

ARTICLE; ATROPHY; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HALF LIFE TIME; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FIBROSIS; KIDNEY TUBULE ATROPHY; MALE; MASS SPECTROMETRY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEOMICS;

EID: 59949097714     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2007101137     Document Type: Article

References (31)

1. US Renal Data System: US Renal Data System: Excerpts from the USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Am J Kidney Dis 42: s1-s230, 2003
2. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725-1730, 1999
3. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, Muirhead N: A study of the quality of life and cost-utility of renal transplantation. Kidney Int 50: 235-242, 1996
4. Paul LC: Chronic allograft nephropathy: An update. Kidney Int 56: 783-793, 1999
5. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RDM, Jeremy R, Chapman JR: The natural history of chronic allograft nephropathy. N Engl J Med 349: 2326 -2333, 2003
6. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK: Long-term survival in renal transplant recipients with graft function. Kidney Int 57: 307-313, 2000
7. Chapman JR. Longitudinal analysis of chronic allograft nephropathy: Clinicopathologic correlations. Kidney Int Suppl S108-S112, 2005
8. Kaplan B, Meier-Kriesche HU: Death after graft loss: An important late study endpoint in kidney transplantation. Am J Transplant 2: 970-974, 2002
9. Knoll G, Muirhead N, Trpeski L, Zhu N, Badovinac K: Patient survival following renal transplant failure in Canada. Am J Transplant 5: 1719 -1724, 2005
10. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Carvallo T: The Banff 97 working classification for renal allograft pathology. Kidney Int 55: 713-723, 1999
11. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nankivell BJ, Nickeleit V, Papadimitriou JC, Platt LJ, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ: Banff '05 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 7: 518-526, 2007
12. Hillenkamp F, Karas M, Beavis RC, Chait BT: Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Anal Chem 63: 1193A-1203A, 1991
13. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, White BC, Roberts JR, Edgerton M, Gonzalez A, Nadaf S, Moore JH, Caprioli RM, Carbone DP: Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362: 433-439, 1991
14. 14.Yanagisawa K, Tomida S, Shimada Y, Yatabe Y, Mitsudomi T, Takahashi T: A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst 99: 858-867, 2007
15. Schwartz SA, Weil RJ, Johnson MD, Toms SA, Caprioli RM: Protein profiling in brain tumors using mass spectrometry: Feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10: 981-987, 2004
16. Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP: Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 237: 660-664, 2003
17. Woroniecki RP, Orlova TN, Mendelev N, Shatat IF, Hailpern SM, Kaskel FJ, Goligorsky MS, O'Riordan E: Urinary proteome of steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome of childhood. Am J Nephrol 26: 258 -267, 2006
18. Schaub S, Rush D, Wilkins J, Gibson IW, Weiler T, Sangster K, Nicolle L, Karpinski M, Jeffery J, Nickerson P: Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 15: 219 -227, 2004
19. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98: 5116-5121, 2001
20. Saeed AI, Sharon V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J: TM4: A free, open-source system for microarray dates management and analysis. Biotechniques 34: 374-378, 2003
21. Zerefos P, Prados J, Kossida S, Kalousis A, Vlahou A: Sample preparation and bioinformatics in MALDI profiling of urinary proteins. J Chromatogr B Analyt Technol Biomed Life Sci 853: 20-30, 2007
22. Prados J, Kalousis A, Sanchez JC, Allard L, Carrette O, Hilario M: Mining mass spectra fordiagnosis and biomarker discovery of cerebral accidents. Proteomics 4: 2320-2332, 2004
23. Serón D, Moreso F, BoverJ Condom E, Gil-Vernet S, Cañas C, Fulladosa X, Torras J, Carrera M, Grinyó JM, Alsina J: Early protocol renal allograft biopsies and graft outcome. Kidney Int 51: 310-316, 1997
24. Yilmaz S, Tomlanovich S, Mathew T, Taskinen E, Paavonen T, Navarro M, Ramos E, Hooftman L, Hayry P: Protocol core needle biopsy and histologic chronic allograft damage index (CADI) as surrogate end-point for long term graft survival in multicenter studies. J Am Soc Nephrol 14: 773-779, 2003
25. Nankivell BJ, Fenton-Lee CA, Kuypers DRJ, Cheung E, Allen RD, O'Connell PJ, Chapman JR: Effect of histological damage on long-term kidney transplant outcome. Transplantation 71: 515-523, 2001
26. Cosio FG, Grande JP, Wadei H, Larson T, Griffin M, Stegall M: Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 5: 2464-2472, 2005
27. Haas M, Montgomery RA, Segev DL Rahman MH, Racusen LC, Bag-nasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES: Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 6: 1-10, 2006
28. Serón D, Moreso F: Protocol biopsies in renal transplantation: Prognostic value of structural monitoring Kidney Int 72: 690-697, 2007
29. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns J-P, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria-An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3: 708714, 2003
30. Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF. Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 4: 124-129, 2004
31. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577, 1993 [erratum appears in Clin Chem 39: 1589, 1993]